Actionable news
All posts from Actionable news
Actionable news in ACAD: ACADIA Pharmaceuticals Inc.,

ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals, Inc. has a fundamental score of 28 and has a relative valuation of OVERVALUED. ACADIA Pharmaceuticals, Inc. is on the bottom right quadrant of CapitalCube's Value - Price Matrix. We therefore classify ACADIA Pharmaceuticals, Inc. as 'Speculative'. In other words, not only is ACADIA Pharmaceuticals, Inc.'s Fundamental Analysis Score low at 28, but it is also potentially overvalued, in that it trades at a price higher than its CapitalCube Implied Price of 10.82.SpreadsheetACADIA Pharmaceuticals, Inc.'s price of USD 27.95 is greater than CapitalCube's implied price of USD 10.82. At this level, CapitalCube believes that...